| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anion Transport Proteins | 12 | 2016 | 30 | 1.900 |
Why?
|
| COUP Transcription Factor I | 9 | 2020 | 91 | 1.330 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2023 | 232 | 1.160 |
Why?
|
| Ear, Inner | 4 | 2013 | 51 | 1.120 |
Why?
|
| Hair Cells, Auditory | 7 | 2020 | 62 | 1.100 |
Why?
|
| Cell Membrane | 8 | 2017 | 459 | 0.960 |
Why?
|
| HIV Seropositivity | 1 | 2023 | 117 | 0.820 |
Why?
|
| Hair Cells, Auditory, Outer | 7 | 2017 | 69 | 0.760 |
Why?
|
| HIV-1 | 1 | 2023 | 463 | 0.670 |
Why?
|
| Cochlea | 11 | 2021 | 85 | 0.630 |
Why?
|
| HIV Infections | 2 | 2023 | 1873 | 0.570 |
Why?
|
| Receptors, Steroid | 4 | 2005 | 273 | 0.550 |
Why?
|
| Molecular Motor Proteins | 8 | 2017 | 29 | 0.530 |
Why?
|
| DNA-Binding Proteins | 10 | 2005 | 2056 | 0.520 |
Why?
|
| Organ of Corti | 5 | 2013 | 26 | 0.520 |
Why?
|
| Transcription Factors | 9 | 2005 | 2607 | 0.440 |
Why?
|
| Gene Expression Regulation, Developmental | 7 | 2013 | 1001 | 0.430 |
Why?
|
| Membrane Microdomains | 3 | 2009 | 60 | 0.420 |
Why?
|
| Animals | 48 | 2021 | 34158 | 0.420 |
Why?
|
| Mice | 36 | 2021 | 17757 | 0.420 |
Why?
|
| Antioxidants | 1 | 2015 | 339 | 0.400 |
Why?
|
| Gene Regulatory Networks | 2 | 2018 | 353 | 0.400 |
Why?
|
| Hyperkinesis | 1 | 2012 | 23 | 0.390 |
Why?
|
| Evolution, Molecular | 4 | 2015 | 672 | 0.390 |
Why?
|
| Deafness | 2 | 2012 | 82 | 0.380 |
Why?
|
| Mutagenesis, Insertional | 1 | 2012 | 147 | 0.370 |
Why?
|
| Receptor, Adenosine A2B | 2 | 2021 | 11 | 0.370 |
Why?
|
| Gene Expression Regulation | 4 | 2016 | 2535 | 0.330 |
Why?
|
| Gerbillinae | 5 | 2016 | 55 | 0.330 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2021 | 141 | 0.320 |
Why?
|
| Trehalose | 2 | 2018 | 20 | 0.290 |
Why?
|
| Electric Capacitance | 3 | 2016 | 13 | 0.290 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2009 | 354 | 0.290 |
Why?
|
| Hearing Loss | 4 | 2017 | 132 | 0.290 |
Why?
|
| Mice, Inbred C57BL | 13 | 2021 | 4434 | 0.280 |
Why?
|
| Directed Molecular Evolution | 1 | 2006 | 11 | 0.280 |
Why?
|
| Patch-Clamp Techniques | 6 | 2016 | 281 | 0.270 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 3 | 2015 | 384 | 0.270 |
Why?
|
| MicroRNAs | 1 | 2013 | 839 | 0.270 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 5 | 2017 | 382 | 0.270 |
Why?
|
| Crassostrea | 1 | 2015 | 4 | 0.250 |
Why?
|
| Receptors, Notch | 2 | 2006 | 203 | 0.240 |
Why?
|
| Membrane Potentials | 4 | 2017 | 304 | 0.230 |
Why?
|
| Receptors, Androgen | 6 | 1995 | 412 | 0.230 |
Why?
|
| Cell Differentiation | 5 | 2013 | 1932 | 0.220 |
Why?
|
| Mice, Knockout | 11 | 2020 | 3761 | 0.220 |
Why?
|
| Chromosome Disorders | 2 | 2018 | 312 | 0.210 |
Why?
|
| Protein Transport | 4 | 2015 | 368 | 0.210 |
Why?
|
| Astrocytes | 3 | 2021 | 252 | 0.210 |
Why?
|
| Molecular Sequence Data | 9 | 2015 | 3872 | 0.210 |
Why?
|
| Gene Expression | 5 | 2020 | 1570 | 0.210 |
Why?
|
| Genome-Wide Association Study | 1 | 2010 | 1653 | 0.200 |
Why?
|
| Embryonic and Fetal Development | 4 | 2001 | 132 | 0.200 |
Why?
|
| beta-Galactosidase | 2 | 2007 | 145 | 0.200 |
Why?
|
| Cholesterol | 4 | 2009 | 533 | 0.200 |
Why?
|
| Aldehyde Dehydrogenase | 2 | 1993 | 40 | 0.190 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2024 | 187 | 0.190 |
Why?
|
| Stria Vascularis | 1 | 2021 | 4 | 0.190 |
Why?
|
| Histocytological Preparation Techniques | 1 | 2001 | 5 | 0.190 |
Why?
|
| Auditory Pathways | 1 | 2021 | 19 | 0.190 |
Why?
|
| Mediator Complex | 1 | 2021 | 52 | 0.180 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2024 | 237 | 0.180 |
Why?
|
| Electrophysiology | 4 | 2016 | 269 | 0.180 |
Why?
|
| Patient Compliance | 1 | 2024 | 471 | 0.180 |
Why?
|
| Androgen-Binding Protein | 2 | 1991 | 26 | 0.180 |
Why?
|
| Biotinylation | 2 | 2011 | 21 | 0.180 |
Why?
|
| Early Detection of Cancer | 1 | 2024 | 354 | 0.180 |
Why?
|
| Epithelial Cells | 1 | 2005 | 908 | 0.180 |
Why?
|
| Erythrocytes | 1 | 2021 | 207 | 0.170 |
Why?
|
| Humans | 34 | 2024 | 124270 | 0.170 |
Why?
|
| Optic Atrophies, Hereditary | 1 | 2020 | 16 | 0.170 |
Why?
|
| Cell Line | 8 | 2008 | 2770 | 0.170 |
Why?
|
| Skin | 4 | 1993 | 511 | 0.170 |
Why?
|
| Hypoxia | 1 | 2021 | 249 | 0.160 |
Why?
|
| Virulence Factors | 1 | 2020 | 173 | 0.160 |
Why?
|
| Aging | 3 | 2021 | 1197 | 0.160 |
Why?
|
| HEK293 Cells | 3 | 2017 | 749 | 0.160 |
Why?
|
| Base Sequence | 6 | 2018 | 3093 | 0.160 |
Why?
|
| COUP Transcription Factors | 4 | 2005 | 43 | 0.160 |
Why?
|
| Proteins | 6 | 2013 | 1042 | 0.160 |
Why?
|
| Acetylglucosaminidase | 1 | 2018 | 17 | 0.150 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2018 | 178 | 0.150 |
Why?
|
| Cells, Cultured | 7 | 2017 | 3057 | 0.150 |
Why?
|
| Transfection | 4 | 2009 | 1069 | 0.150 |
Why?
|
| Deubiquitinating Enzymes | 1 | 2018 | 13 | 0.150 |
Why?
|
| Neovascularization, Physiologic | 1 | 1999 | 208 | 0.150 |
Why?
|
| Diflunisal | 1 | 2017 | 1 | 0.150 |
Why?
|
| COUP Transcription Factor II | 4 | 2005 | 117 | 0.150 |
Why?
|
| Alleles | 4 | 2017 | 1611 | 0.150 |
Why?
|
| Cognitive Dysfunction | 1 | 2021 | 231 | 0.140 |
Why?
|
| Memory Disorders | 1 | 2020 | 237 | 0.140 |
Why?
|
| Neuronal Plasticity | 1 | 2020 | 272 | 0.140 |
Why?
|
| Endopeptidases | 1 | 2018 | 113 | 0.140 |
Why?
|
| Green Fluorescent Proteins | 5 | 2009 | 392 | 0.140 |
Why?
|
| Mice, Transgenic | 5 | 2017 | 2417 | 0.140 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2011 | 768 | 0.140 |
Why?
|
| Retinal Degeneration | 1 | 2018 | 93 | 0.140 |
Why?
|
| In Situ Hybridization | 4 | 2006 | 471 | 0.140 |
Why?
|
| Chlorides | 1 | 2017 | 106 | 0.140 |
Why?
|
| Repressor Proteins | 3 | 2013 | 821 | 0.140 |
Why?
|
| Autophagy | 2 | 2018 | 395 | 0.140 |
Why?
|
| Androgen-Insensitivity Syndrome | 2 | 1995 | 28 | 0.130 |
Why?
|
| Ion Transport | 1 | 2016 | 52 | 0.130 |
Why?
|
| Hippocampus | 2 | 2020 | 828 | 0.130 |
Why?
|
| Nonlinear Dynamics | 1 | 2016 | 51 | 0.130 |
Why?
|
| Amino Acid Sequence | 5 | 2015 | 2697 | 0.130 |
Why?
|
| Time Factors | 3 | 2016 | 6252 | 0.130 |
Why?
|
| Kidney | 3 | 2009 | 1346 | 0.130 |
Why?
|
| Cell Survival | 2 | 2015 | 807 | 0.120 |
Why?
|
| Doxycycline | 1 | 2016 | 117 | 0.120 |
Why?
|
| Neurons | 6 | 2017 | 1972 | 0.120 |
Why?
|
| Neuroprotective Agents | 1 | 2017 | 156 | 0.120 |
Why?
|
| Models, Biological | 3 | 2013 | 1460 | 0.120 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 305 | 0.120 |
Why?
|
| Inflammation | 2 | 2021 | 1414 | 0.120 |
Why?
|
| Texas | 1 | 2023 | 3586 | 0.120 |
Why?
|
| Movement Disorders | 1 | 2017 | 222 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 488 | 0.110 |
Why?
|
| Hearing Loss, Noise-Induced | 1 | 2013 | 6 | 0.110 |
Why?
|
| Mutagenesis | 2 | 2009 | 347 | 0.110 |
Why?
|
| Heart | 1 | 1999 | 724 | 0.110 |
Why?
|
| Neurodegenerative Diseases | 1 | 2017 | 251 | 0.110 |
Why?
|
| Chromosome Deletion | 2 | 2018 | 647 | 0.110 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 4 | 2021 | 22 | 0.110 |
Why?
|
| Cell Nucleus | 3 | 2018 | 677 | 0.110 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2016 | 309 | 0.110 |
Why?
|
| Embryo, Mammalian | 3 | 2013 | 458 | 0.110 |
Why?
|
| 3' Untranslated Regions | 1 | 2013 | 165 | 0.110 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2013 | 109 | 0.110 |
Why?
|
| Gene Deletion | 4 | 2021 | 795 | 0.100 |
Why?
|
| Brain | 3 | 2021 | 3000 | 0.100 |
Why?
|
| Seizures | 1 | 2018 | 877 | 0.100 |
Why?
|
| Organ Specificity | 2 | 2021 | 426 | 0.100 |
Why?
|
| Cochlear Microphonic Potentials | 2 | 2013 | 8 | 0.100 |
Why?
|
| Membrane Glycoproteins | 2 | 2017 | 412 | 0.100 |
Why?
|
| Receptors, Ghrelin | 1 | 2012 | 29 | 0.100 |
Why?
|
| Nervous System Diseases | 1 | 2016 | 376 | 0.100 |
Why?
|
| Disease Progression | 1 | 2018 | 2037 | 0.100 |
Why?
|
| Ghrelin | 1 | 2012 | 54 | 0.100 |
Why?
|
| Body Patterning | 1 | 2012 | 124 | 0.100 |
Why?
|
| Otoacoustic Emissions, Spontaneous | 3 | 2021 | 9 | 0.090 |
Why?
|
| Alcohol Dehydrogenase | 1 | 1991 | 17 | 0.090 |
Why?
|
| Depression | 1 | 2020 | 1243 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2013 | 701 | 0.090 |
Why?
|
| Embryonic Development | 1 | 2013 | 211 | 0.090 |
Why?
|
| Leptin | 1 | 2012 | 214 | 0.090 |
Why?
|
| Membrane Lipids | 2 | 2008 | 33 | 0.090 |
Why?
|
| Intellectual Disability | 1 | 2018 | 1061 | 0.090 |
Why?
|
| Protein Structure, Secondary | 2 | 2009 | 239 | 0.090 |
Why?
|
| Cysteine | 2 | 2009 | 135 | 0.090 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2009 | 12 | 0.080 |
Why?
|
| Binding Sites | 2 | 2010 | 1295 | 0.080 |
Why?
|
| Mutation | 7 | 2010 | 5804 | 0.080 |
Why?
|
| HeLa Cells | 2 | 2017 | 808 | 0.080 |
Why?
|
| Hearing | 2 | 2007 | 52 | 0.080 |
Why?
|
| Glycosylation | 1 | 2009 | 121 | 0.080 |
Why?
|
| Markov Chains | 1 | 2010 | 84 | 0.080 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2010 | 152 | 0.080 |
Why?
|
| Structure-Activity Relationship | 2 | 2009 | 568 | 0.080 |
Why?
|
| Male | 15 | 2021 | 60887 | 0.080 |
Why?
|
| Membrane Proteins | 2 | 2009 | 1522 | 0.080 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 393 | 0.080 |
Why?
|
| Adenoviridae | 2 | 2008 | 604 | 0.070 |
Why?
|
| Fibroblasts | 6 | 2017 | 892 | 0.070 |
Why?
|
| Helper Viruses | 1 | 2007 | 45 | 0.070 |
Why?
|
| Fluorescent Dyes | 2 | 2007 | 260 | 0.070 |
Why?
|
| Glucose | 1 | 2012 | 886 | 0.070 |
Why?
|
| Signal Transduction | 5 | 2020 | 4533 | 0.070 |
Why?
|
| beta-Cyclodextrins | 1 | 2007 | 12 | 0.070 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2007 | 97 | 0.070 |
Why?
|
| Renilla | 1 | 2006 | 3 | 0.070 |
Why?
|
| Intracellular Membranes | 1 | 2007 | 63 | 0.070 |
Why?
|
| Organic Anion Transporters | 1 | 2006 | 16 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 1289 | 0.070 |
Why?
|
| Phylogeny | 2 | 2015 | 696 | 0.070 |
Why?
|
| Abnormalities, Multiple | 1 | 2013 | 963 | 0.070 |
Why?
|
| Golgi Apparatus | 1 | 2007 | 93 | 0.070 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2007 | 60 | 0.070 |
Why?
|
| Endosomes | 1 | 2007 | 65 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 1115 | 0.070 |
Why?
|
| Female | 12 | 2024 | 66294 | 0.070 |
Why?
|
| DNA Mutational Analysis | 1 | 2009 | 788 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 3125 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 1014 | 0.070 |
Why?
|
| Protein Interaction Mapping | 1 | 2006 | 84 | 0.070 |
Why?
|
| Glycosyltransferases | 1 | 2006 | 25 | 0.070 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2006 | 61 | 0.070 |
Why?
|
| Behavior, Animal | 2 | 2020 | 492 | 0.070 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2006 | 64 | 0.060 |
Why?
|
| Gene Transfer Techniques | 1 | 2007 | 358 | 0.060 |
Why?
|
| Endoplasmic Reticulum | 1 | 2007 | 221 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2006 | 459 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 2 | 2009 | 1763 | 0.060 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2006 | 174 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 3 | 2006 | 1583 | 0.060 |
Why?
|
| Guanine | 1 | 2005 | 60 | 0.060 |
Why?
|
| Genitalia | 3 | 1990 | 36 | 0.060 |
Why?
|
| Ovalbumin | 2 | 1996 | 318 | 0.060 |
Why?
|
| Trans-Activators | 2 | 2000 | 808 | 0.060 |
Why?
|
| Adenine | 1 | 2005 | 101 | 0.060 |
Why?
|
| RNA, Messenger | 5 | 2013 | 2823 | 0.060 |
Why?
|
| Conserved Sequence | 1 | 2015 | 293 | 0.060 |
Why?
|
| Protein Binding | 2 | 2015 | 1742 | 0.060 |
Why?
|
| Models, Anatomic | 1 | 2005 | 98 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2006 | 1107 | 0.060 |
Why?
|
| Triglycerides | 1 | 2006 | 567 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2005 | 1690 | 0.050 |
Why?
|
| Gene Knock-In Techniques | 2 | 2017 | 124 | 0.050 |
Why?
|
| Serine | 2 | 2017 | 173 | 0.050 |
Why?
|
| Molecular Weight | 4 | 1991 | 392 | 0.050 |
Why?
|
| Genetic Variation | 2 | 2009 | 1492 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 1688 | 0.050 |
Why?
|
| Genitalia, Male | 2 | 1993 | 38 | 0.050 |
Why?
|
| Gene Targeting | 2 | 2001 | 178 | 0.050 |
Why?
|
| Phenotype | 4 | 2018 | 4256 | 0.050 |
Why?
|
| Freezing Reaction, Cataleptic | 1 | 2021 | 5 | 0.050 |
Why?
|
| Cytosol | 2 | 1993 | 161 | 0.050 |
Why?
|
| 2,3-Diphosphoglycerate | 1 | 2021 | 3 | 0.050 |
Why?
|
| Bisphosphoglycerate Mutase | 1 | 2021 | 3 | 0.050 |
Why?
|
| Reflex, Startle | 1 | 2021 | 32 | 0.050 |
Why?
|
| Tissue Preservation | 1 | 2001 | 15 | 0.050 |
Why?
|
| Conditioning, Classical | 1 | 2021 | 53 | 0.050 |
Why?
|
| Limb Buds | 1 | 2001 | 7 | 0.050 |
Why?
|
| Tail | 1 | 2001 | 16 | 0.050 |
Why?
|
| Gene Knockout Techniques | 1 | 2021 | 125 | 0.050 |
Why?
|
| Spiral Ganglion | 1 | 2000 | 10 | 0.050 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2000 | 41 | 0.050 |
Why?
|
| Choristoma | 1 | 2001 | 49 | 0.040 |
Why?
|
| Glycolysis | 1 | 2021 | 147 | 0.040 |
Why?
|
| Drug Resistance | 2 | 1993 | 256 | 0.040 |
Why?
|
| Obesity | 1 | 2012 | 2253 | 0.040 |
Why?
|
| Vestibule, Labyrinth | 1 | 2000 | 43 | 0.040 |
Why?
|
| Microglia | 1 | 2021 | 96 | 0.040 |
Why?
|
| Nerve Fibers | 1 | 2020 | 72 | 0.040 |
Why?
|
| Random Allocation | 1 | 2021 | 435 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 2021 | 224 | 0.040 |
Why?
|
| Embryo, Nonmammalian | 1 | 2000 | 144 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2021 | 623 | 0.040 |
Why?
|
| Fear | 1 | 2021 | 201 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 235 | 0.040 |
Why?
|
| Adenosine | 1 | 2020 | 127 | 0.040 |
Why?
|
| Myelin Sheath | 1 | 2020 | 132 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2002 | 553 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2006 | 2303 | 0.040 |
Why?
|
| Receptors, Glucocorticoid | 1 | 1999 | 122 | 0.040 |
Why?
|
| Genotype | 1 | 2005 | 2548 | 0.040 |
Why?
|
| Thalamus | 1 | 1999 | 85 | 0.040 |
Why?
|
| Mucopolysaccharidosis III | 1 | 2018 | 13 | 0.040 |
Why?
|
| Vacuoles | 1 | 2018 | 23 | 0.040 |
Why?
|
| Transcriptional Activation | 2 | 2018 | 483 | 0.040 |
Why?
|
| Syndrome | 2 | 1993 | 1120 | 0.040 |
Why?
|
| Placenta | 1 | 2002 | 507 | 0.040 |
Why?
|
| Retinal Bipolar Cells | 1 | 2018 | 38 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 2 | 2011 | 753 | 0.040 |
Why?
|
| Axons | 2 | 1999 | 391 | 0.040 |
Why?
|
| Morphogenesis | 2 | 1997 | 212 | 0.040 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2018 | 82 | 0.040 |
Why?
|
| Biomarkers | 1 | 2007 | 2974 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2024 | 849 | 0.040 |
Why?
|
| Glossopharyngeal Nerve | 1 | 1997 | 7 | 0.040 |
Why?
|
| Ganglia | 1 | 1997 | 20 | 0.040 |
Why?
|
| Dendritic Spines | 1 | 2018 | 60 | 0.040 |
Why?
|
| Microscopy, Confocal | 2 | 2009 | 349 | 0.040 |
Why?
|
| Protein Biosynthesis | 2 | 1991 | 665 | 0.040 |
Why?
|
| Animals, Newborn | 2 | 2013 | 1006 | 0.040 |
Why?
|
| Macrophages | 1 | 2021 | 618 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2018 | 159 | 0.030 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1997 | 114 | 0.030 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2017 | 40 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 101 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 4353 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 1999 | 449 | 0.030 |
Why?
|
| Lysosomes | 1 | 2018 | 235 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2017 | 1622 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2017 | 164 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 2017 | 168 | 0.030 |
Why?
|
| Homozygote | 1 | 2018 | 532 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 355 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 1997 | 1341 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 3412 | 0.030 |
Why?
|
| Coronary Vessels | 1 | 1999 | 536 | 0.030 |
Why?
|
| Action Potentials | 1 | 2018 | 501 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 1478 | 0.030 |
Why?
|
| Genes, Reporter | 2 | 2007 | 384 | 0.030 |
Why?
|
| Synapses | 1 | 2018 | 457 | 0.030 |
Why?
|
| Noise | 1 | 2013 | 19 | 0.030 |
Why?
|
| Labyrinth Supporting Cells | 1 | 2013 | 4 | 0.030 |
Why?
|
| Point Mutation | 1 | 1995 | 348 | 0.030 |
Why?
|
| Immunochemistry | 2 | 1990 | 30 | 0.030 |
Why?
|
| Ethylnitrosourea | 1 | 2013 | 10 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2018 | 868 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2013 | 158 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2017 | 863 | 0.030 |
Why?
|
| RNA, Untranslated | 1 | 2013 | 112 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2013 | 139 | 0.030 |
Why?
|
| Chromosomes | 1 | 2013 | 199 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2012 | 78 | 0.020 |
Why?
|
| Isoenzymes | 1 | 1993 | 227 | 0.020 |
Why?
|
| Disorders of Sex Development | 1 | 1992 | 78 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2013 | 969 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2013 | 364 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2012 | 210 | 0.020 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2011 | 19 | 0.020 |
Why?
|
| Biotin | 1 | 2011 | 45 | 0.020 |
Why?
|
| Poly A | 1 | 1991 | 59 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 1014 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 1991 | 259 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1991 | 396 | 0.020 |
Why?
|
| DNA | 2 | 1997 | 1599 | 0.020 |
Why?
|
| Gene Library | 1 | 1991 | 220 | 0.020 |
Why?
|
| Tectorial Membrane | 1 | 2010 | 5 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2012 | 222 | 0.020 |
Why?
|
| Young Adult | 1 | 2024 | 8954 | 0.020 |
Why?
|
| Epilepsy | 1 | 2018 | 867 | 0.020 |
Why?
|
| Peptide Mapping | 1 | 1990 | 44 | 0.020 |
Why?
|
| Recombination, Genetic | 2 | 2002 | 447 | 0.020 |
Why?
|
| Affinity Labels | 1 | 1989 | 15 | 0.020 |
Why?
|
| Electrophysiological Phenomena | 1 | 2010 | 68 | 0.020 |
Why?
|
| Metabolome | 1 | 2012 | 294 | 0.020 |
Why?
|
| Disulfides | 1 | 2009 | 78 | 0.020 |
Why?
|
| Connexin 26 | 1 | 2009 | 13 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2010 | 98 | 0.020 |
Why?
|
| Dihydrotestosterone | 1 | 1989 | 67 | 0.020 |
Why?
|
| Valine | 1 | 2009 | 107 | 0.020 |
Why?
|
| Connexins | 1 | 2009 | 59 | 0.020 |
Why?
|
| Body Weight | 1 | 2013 | 1009 | 0.020 |
Why?
|
| Electric Conductivity | 1 | 2008 | 89 | 0.020 |
Why?
|
| DNA Primers | 1 | 2009 | 660 | 0.020 |
Why?
|
| Homeostasis | 1 | 2012 | 688 | 0.020 |
Why?
|
| Cell Death | 2 | 1999 | 240 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2008 | 154 | 0.020 |
Why?
|
| Lac Operon | 1 | 2007 | 95 | 0.020 |
Why?
|
| Electrodes | 1 | 2007 | 97 | 0.020 |
Why?
|
| Haplotypes | 1 | 2009 | 517 | 0.020 |
Why?
|
| RNA | 1 | 1991 | 568 | 0.020 |
Why?
|
| Membrane Fluidity | 1 | 2007 | 18 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2008 | 289 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2008 | 892 | 0.020 |
Why?
|
| Epithelium | 1 | 2007 | 360 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2007 | 172 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2007 | 244 | 0.020 |
Why?
|
| Age Factors | 1 | 2013 | 2812 | 0.020 |
Why?
|
| Androgens | 1 | 1988 | 275 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 807 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2006 | 257 | 0.020 |
Why?
|
| Middle Aged | 2 | 2024 | 26367 | 0.020 |
Why?
|
| Hair Cells, Vestibular | 1 | 2005 | 10 | 0.020 |
Why?
|
| Pan troglodytes | 1 | 2005 | 71 | 0.020 |
Why?
|
| RNA, Ribosomal | 1 | 2005 | 63 | 0.020 |
Why?
|
| RNA Splice Sites | 1 | 2005 | 87 | 0.020 |
Why?
|
| Cell Movement | 1 | 2008 | 836 | 0.010 |
Why?
|
| Zebrafish Proteins | 1 | 2005 | 111 | 0.010 |
Why?
|
| Introns | 1 | 2005 | 300 | 0.010 |
Why?
|
| DNA, Mitochondrial | 1 | 2005 | 211 | 0.010 |
Why?
|
| Transcription, Genetic | 2 | 2002 | 1701 | 0.010 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 2 | 1995 | 49 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2005 | 625 | 0.010 |
Why?
|
| Presenilin-2 | 1 | 2003 | 18 | 0.010 |
Why?
|
| Adult | 1 | 2024 | 29357 | 0.010 |
Why?
|
| Presenilin-1 | 1 | 2003 | 53 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 2005 | 350 | 0.010 |
Why?
|
| Body Constitution | 1 | 2002 | 37 | 0.010 |
Why?
|
| Zebrafish | 1 | 2005 | 388 | 0.010 |
Why?
|
| Embryo Loss | 1 | 2002 | 26 | 0.010 |
Why?
|
| Exons | 1 | 2005 | 796 | 0.010 |
Why?
|
| Placentation | 1 | 2002 | 55 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2009 | 3261 | 0.010 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2002 | 72 | 0.010 |
Why?
|
| Nuclear Receptor Subfamily 6, Group A, Member 1 | 1 | 2001 | 11 | 0.010 |
Why?
|
| Somites | 1 | 2001 | 9 | 0.010 |
Why?
|
| Cochlear Duct | 1 | 2000 | 5 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 2001 | 99 | 0.010 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2000 | 52 | 0.010 |
Why?
|
| Acoustic Stimulation | 1 | 2000 | 85 | 0.010 |
Why?
|
| Fetal Growth Retardation | 1 | 2002 | 240 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 1887 | 0.010 |
Why?
|
| Fetal Death | 1 | 2001 | 113 | 0.010 |
Why?
|
| Carbocyanines | 1 | 1999 | 13 | 0.010 |
Why?
|
| Brain Stem | 1 | 2000 | 115 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2000 | 388 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 1999 | 60 | 0.010 |
Why?
|
| Pedigree | 2 | 1995 | 1597 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2009 | 4727 | 0.010 |
Why?
|
| Antimetabolites | 1 | 1999 | 33 | 0.010 |
Why?
|
| Postural Balance | 1 | 2000 | 125 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2001 | 606 | 0.010 |
Why?
|
| Rats | 1 | 2005 | 3688 | 0.010 |
Why?
|
| Marine Toxins | 1 | 1997 | 7 | 0.010 |
Why?
|
| Okadaic Acid | 1 | 1997 | 14 | 0.010 |
Why?
|
| Oxazoles | 1 | 1997 | 23 | 0.010 |
Why?
|
| Neural Pathways | 1 | 1999 | 266 | 0.010 |
Why?
|
| Rhombencephalon | 1 | 1997 | 46 | 0.010 |
Why?
|
| Neural Crest | 1 | 1997 | 51 | 0.010 |
Why?
|
| Hedgehog Proteins | 1 | 1997 | 189 | 0.010 |
Why?
|
| Sequence Homology | 1 | 1996 | 62 | 0.010 |
Why?
|
| Receptors, Retinoic Acid | 1 | 1996 | 100 | 0.010 |
Why?
|
| Chickens | 1 | 1996 | 638 | 0.010 |
Why?
|
| Deoxyribonuclease HpaII | 1 | 1995 | 8 | 0.010 |
Why?
|
| Manitoba | 1 | 1995 | 3 | 0.010 |
Why?
|
| Species Specificity | 1 | 1996 | 550 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1995 | 143 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 1997 | 579 | 0.010 |
Why?
|
| Genetic Carrier Screening | 1 | 1995 | 75 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1995 | 464 | 0.010 |
Why?
|
| Apoptosis | 1 | 2000 | 1790 | 0.010 |
Why?
|
| X Chromosome | 1 | 1995 | 337 | 0.010 |
Why?
|
| Histidine | 1 | 1992 | 72 | 0.010 |
Why?
|
| Canada | 1 | 1992 | 294 | 0.010 |
Why?
|
| Arginine | 1 | 1992 | 332 | 0.010 |
Why?
|
| Photofluorography | 1 | 1989 | 1 | 0.010 |
Why?
|
| Photochemistry | 1 | 1989 | 22 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 1989 | 25 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1989 | 43 | 0.010 |
Why?
|
| Pregnancy | 1 | 2002 | 7248 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1989 | 313 | 0.000 |
Why?
|
| Isoelectric Point | 1 | 1988 | 18 | 0.000 |
Why?
|
| Photolysis | 1 | 1988 | 9 | 0.000 |
Why?
|
| Estrenes | 1 | 1988 | 21 | 0.000 |
Why?
|
| Metribolone | 1 | 1988 | 29 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1989 | 1015 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1995 | 14052 | 0.000 |
Why?
|
| Adolescent | 1 | 1992 | 19308 | 0.000 |
Why?
|